経皮的電気神経刺激（TENS）の世界市場：製品タイプ別、用途別、最終用途別、地域別の市場規模、シェアおよび動向分析、セグメント別の予測（2022年～2030年）

世界の経皮的電気神経刺激（TENS）市場は、2030年までに4億1,948万米ドルに達し、2022年～2030年の間に3.84%のCAGRで成長すると予想されます。

市場成長の主な要因は、慢性疼痛やスポーツ傷害の症例の増加、高齢者人口の増加です。また、理学療法士の間でTENSへの嗜好が高まっていることも、市場成長の一因となっています。

当レポートでは、世界の経皮的電気神経刺激（TENS）市場について調査分析し、市場の動向、セグメント別・地域別の市場分析、競合情勢などを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経皮的電気神経刺激（TENS）市場：変数、動向および範囲

• 市場系統の見通し
• 浸透と成長の見通しのマッピング
• ユーザーの視点分析
• 主要なエンドユーザーのリスト
• 市場力学
• 経皮的電気神経刺激（TENS）：市場分析ツール
• COVID-19の市場への影響

第4章 経皮的電気神経刺激（TENS）市場：セグメント分析 - 製品タイプ別（2017年～2030年）

• 定義と範囲
• 製品タイプ別の市場シェア分析（2021年・2030年）
• セグメントダッシュボード
• 世界の経皮的電気神経刺激（TENS）市場：製品タイプ別（2017年～2030年）
• 市場規模と予測、動向分析（2017年～2030年）
  • ポータブル型TENS
  • 卓上型TENS

第5章 経皮的電気神経刺激（TENS）市場：セグメント分析 - 用途別（2017年～2030年）

• 定義と範囲
• 用途別の市場シェア分析（2021年・2030年）
• セグメントダッシュボード
• 世界の経皮的電気神経刺激（TENS）市場：用途別（2017年～2030年）
• 市場規模と予測、動向分析（2017年～2030年）
  • 慢性疼痛
  • 急性疼痛

第6章 経皮的電気神経刺激（TENS）市場：セグメント分析 - 最終用途別（2017年～2030年）

• 定義と範囲
• 最終用途別の市場シェア分析（2021年・2030年）
• セグメントダッシュボード
• 世界の経皮的電気神経刺激（TENS）市場：最終用途別（2017年～2030年）
• 市場規模と予測、動向分析（2017年～2030年）
  • 病院
  • 理学療法クリニック
  • リハビリテーションセンター
  • 在宅ケア
  • その他

第7章 経皮的電気神経刺激（TENS）市場：地域市場分析 - 製品タイプ別、用途別、最終用途別（2017年～2030年）

• 定義と範囲
• 地域市場シェア分析（2021年・2030年）
• 地域市場ダッシュボード
• 地域市場のスナップショット
• 市場規模と予測、動向分析（2020年～2028年）
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア

第8章 経皮的電気神経刺激（TENS）市場：競合分析

• 最近の動向と影響分析：主要な市場参入企業別
• 企業の分類
  • イノベーター
  • マーケットリーダー
• 企業プロファイル
  • OMRON CORPORATION
  • ZYNEX MEDICAL
  • NEUROMETRIX, INC.
  • EMS PHYSIO LTD.
  • BIOMEDICAL LIFE SYSTEMS
  • DJO GLOBAL, INC.
  • GLOBUS

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
• Table 4. North America transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 5. North America transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 6. North America transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 7. U.S. transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 8. U.S. transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 9. U.S. transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 10. Canada transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 11. Canada transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 12. Canada transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 13. Europe transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
• Table 14. Europe transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 15. Europe transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 16. Europe transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 17. UK transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 18. UK transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 19. UK transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 20. Germany transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 21. Germany transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 22. Germany transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 23. France transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 24. France transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 25. France transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 26. Italy transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 27. Italy transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 28. Italy transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 29. Spain transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 30. Spain transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 31. Spain transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 32. Asia Pacific transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
• Table 33. Asia Pacific transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 34. Asia Pacific transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 35. Asia Pacific transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 36. China transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 37. China transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 38. China transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 39. Japan transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 40. Japan transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 41. Japan transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 42. India transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 43. India transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 44. India transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 45. South Korea transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 46. South Korea transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 47. South Korea transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 48. Australia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 49. Australia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 50. Australia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 51. Latin America transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
• Table 52. Latin America transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 53. Latin America transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 54. Latin America transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 55. Brazil transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 56. Brazil transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 57. Brazil transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 58. Mexico transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 59. Mexico transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 60. Mexico transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 61. Argentina transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 62. Argentina transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 63. Argentina transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 64. Colombia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 65. Colombia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 66. Colombia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 67. Middle East & Africa transcutaneous electrical nerve stimulation market, by country, 2017 - 2030 (USD Million)
• Table 68. Middle East & Africa transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 69. Middle East & Africa transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 70. Middle East & Africa transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 71. South Africa transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 72. South Africa transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 73. South Africa transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 74. Saudi Arabia transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 75. Saudi Arabia transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 76. Saudi Arabia transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)
• Table 77. UAE transcutaneous electrical nerve stimulation market, by product type, 2017 - 2030 (USD Million)
• Table 78. UAE transcutaneous electrical nerve stimulation market, by application, 2017 - 2030 (USD Million)
• Table 79. UAE transcutaneous electrical nerve stimulation market, by end-use, 2017 - 2030 (USD Million)

List of Figures

• Fig. 1 Transcutaneous electrical nerve stimulation market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7. QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2021)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Transcutaneous electrical nerve stimulation market: Product type movement analysis
• Fig. 19 Segment dashboard
• Fig. 20 Transcutaneous electrical nerve stimulation market product type outlook: Key takeaways
• Fig. 21 Portable TENS market, 2017 - 2030 (USD Million)
• Fig. 22 Tabletop TENS market, 2017 - 2030 (USD Million)
• Fig. 23 Transcutaneous electrical nerve stimulation market: Application movement analysis
• Fig. 24 Segment dashboard
• Fig. 25 Transcutaneous electrical nerve stimulation market Application outlook: Key takeaways
• Fig. 26 Chronic pain market, 2017 - 2030 (USD Million)
• Fig. 27 Arthritis market, 2017 - 2030 (USD Million)
• Fig. 28 Fibromyalgia market, 2017 - 2030 (USD Million)
• Fig. 29 Neuropathic Pain market, 2017 - 2030 (USD Million)
• Fig. 30 Others market, 2017 - 2030 (USD Million)
• Fig. 31 Acute pain market, 2017 - 2030 (USD Million)
• Fig. 32 Sports injuries market, 2017 - 2030 (USD Million)
• Fig. 33 Postoperative pain market, 2017 - 2030 (USD Million)
• Fig. 34 Labor pain market, 2017 - 2030 (USD Million)
• Fig. 35 Menstrual pain market, 2017 - 2030 (USD Million)
• Fig. 36 Transcutaneous electrical nerve stimulation market: End-use movement analysis
• Fig. 37 Segment dashboard
• Fig. 38 Transcutaneous electrical nerve stimulation market end-use outlook: Key takeaways
• Fig. 39 Hospital market, 2017 - 2030 (USD Million)
• Fig. 40 Physiotherapy clinics market, 2018 -- 2030 (USD Million)
• Fig. 41 Rehabilitation centers market, 2017 - 2030 (USD Million)
• Fig. 42 Home care market, 2017 - 2030 (USD Million)
• Fig. 43 Others market, 2017 - 2030 (USD Million)
• Fig. 44 Regional outlook, 2021 & 2030
• Fig. 45 Regional market dashboard
• Fig. 46 Regional market place: Key takeaways
• Fig. 47 North America transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 48 U.S transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 49 Canada transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 50 Europe transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 51 UK transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 52 Germany transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 53 France transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 54 Italy transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 55 Netherlands transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 56 Spain transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 57 Sweden transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 58 Asia Pacific transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 59 Japan transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 60 China transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 61 India transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 62 South Korea transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 63 Taiwan transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 64 Australia transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 65 Vietnam transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 66 Latin America transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 67 Brazil transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 68 Mexico transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 69 MEA transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 70 South Africa transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 71 Saudi Arabia transcutaneous electrical nerve stimulation market, 2017 - 2030 (USD Million)
• Fig. 72 Company market share analysis, 2021
• Fig. 73 Market differentiators
• Fig. 74. Regional network map

Transcutaneous Electrical Nerve Stimulation Market Growth & Trends:

The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to expand at a CAGR of 3.84% from 2022 to 2030 according to a new report by Grand View Research, Inc. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.

Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.

The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.

Transcutaneous Electrical Nerve Simulation Market Report Highlights:

• Based on product type, the portable segment dominated the market with a revenue share of 71.70% in 2021 and is anticipated to witness the highest CAGR of 4.0% during the forecast period. Portable TENS would decrease the number of doctor visits for patients, therefore are anticipated to support market growth over the forecast period.

• Based on application, the chronic pain segment is likely to witness the fastest growth in the forecast period, owing to the growing prevalence of chronic pain, especially amongst senior citizens.

• Based on end-use, physiotherapy clinics dominated the market. The growing preference of physiotherapists toward electrotherapy as compared to manual techniques is a major factor driving the growth of this segment.

• On the other hand, the home healthcare segment is anticipated to witness the fastest growth of a CAGR of 4.9% over the forecast period.

• North America dominated the market with the highest revenue share of 43.91% in 2021 owing to the presence of key participants, and the high purchasing power of consumers.

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Product Type
  • 1.1.2 Application
  • 1.1.3 End-Use
  • 1.1.4 Regional Scope
  • 1.1.5 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 GVR'S Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 PRIMARY Research
  • 1.3.5 Details OF Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.6.2 Vplume Price Analysis (Model 2)
    • 1.6.2.1 Approach 2: Volume Price Analysis
• 1.7 List Of Secondary Sources
• 1.8 List Of Primary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Transcutaneous Electrical Nerve Stimulation (TENS) Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 User Perspective Analysis
  • 3.3.1 Consumer Behavior Analysis
  • 3.3.2 Market Influencer Analysis
• 3.4 List Of Key End-Users
• 3.5 Market Dynamics
  • 3.5.1 Market Driver Analysis
    • 3.5.1.1 Rising Cases Of Chronic And Acute Pain
    • 3.5.1.2 Ineffectiveness Of Oral Drugs And Low Preference For Surgical Intervention
    • 3.5.1.3 Rising Geriatric Population
    • 3.5.1.4 Rising Demand For Reduced Hospital Stay
    • 3.5.1.5 Increasing Number Of Surgeries
    • 3.5.1.6 Rising Cases Of Anterior Cruciate Ligament (Acl) Tear, Hip Flexor Strain, And Hamstring Strain Among Sports Players
  • 3.5.2 Market Restraints Analysis
    • 3.5.2.1 Adverse Effects Associated With Devices
    • 3.5.2.2 Increased Cost Of Nerve Stimulation Therapy
• 3.6 Transcutaneous Electrical Nerve Stimulation: Market Analysis Tools
  • 3.6.1 Industry Analysis - PORTER'S
  • 3.6.2 SWOT Analysis, By PEST
• 3.7 Impact Of COVID-19 On Market

Chapter 4 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Segment Analysis, By Product Type, 2017 - 2030 (USD Million)

• 4.1 Definition And Scope
• 4.2 Product Type Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Transcutaneous Electrical Nerve Stimulation Market, By Product Type Type, 2017 To 2030
• 4.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
  • 4.5.1 Portables Tens
    • 4.5.1.1 Portable Tens Market, 2017 - 2030 (USD Million)
  • 4.5.2 Table Top Tens
    • 4.5.2.1 Table Top Tens Market, 2017 - 2030 (USD Million)

Chapter 5 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)

• 5.1 Definition And Scope
• 5.2 Application Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2017 To 2030
• 5.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
  • 5.5.1 Chronic Pain
    • 5.5.1.1 Chronic Pain Market, 2017 - 2030 (USD Million)
    • 5.5.1.1.1 Arthritis Market, 2017 - 2030 (USD Million)
    • 5.5.1.1.2 Back & Neck Pain Market, 2017 - 2030 (USD Million)
    • 5.5.1.1.3 Fibromyalgia Market, 2017 - 2030 (USD Million)
    • 5.5.1.1.4 Neuropathic Pain Market, 2017 - 2030 (USD Million)
    • 5.5.1.1.5 Others Market, 2017 - 2030 (USD Million)
  • 5.5.2 Acute Pain
    • 5.5.2.1 Acute Pain Market, 2017 - 2030 (USD Million)
    • 5.5.2.1.1 Sports Injuries Market, 2017 - 2030 (USD Million)
    • 5.5.2.1.2 Postoperative Pain Market, 2017 - 2030 (USD Million)
    • 5.5.2.1.3 Labor Pain Market, 2017 - 2030 (USD Million)
    • 5.5.2.1.4 Menstrual Pain Market, 2017 - 2030 (USD Million)

Chapter 6 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Segment Analysis, By End-Use, 2017 - 2030 (USD Million)

• 6.1 Definition And Scope
• 6.2 End-Use Market Share Analysis, 2021 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Transcutaneous Electrical Nerve Stimulation Market, By End-Use, 2017 To 2030
• 6.5 Market Size & Forecasts And Trend Analysis, 2017 To 2030
  • 6.5.1 Hospitals
    • 6.5.1.1 Hospitals Market, 2017 - 2030 (USD Million)
  • 6.5.2 Physiotherapy Clinics
    • 6.5.2.1 Physiotherapy Clinics Market, 2017 - 2030 (USD Million)
  • 6.5.3 Rehabilitation Centers
    • 6.5.3.1 Rehabilitation Centers Market, 2017 - 2030 (USD Million)
  • 6.5.4 Home Care
    • 6.5.4.1 Home Care Market, 2017 - 2030 (USD Million)
  • 6.5.5 Others
    • 6.5.5.1 Others Market, 2017 - 2030 (USD Million)

Chapter 7 Transcutaneous Electrical Nerve Stimulation (TENS) Market: Regional Market Analysis, By Product Type, By Application, By End-Use 2017 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2021 & 2030
• 7.3 Regional Market Dashboard
• 7.4 Regional Market Snapshot
• 7.5 Market Size, & Forecasts, And Trend Analysis, 2020 To 2028
• 7.6 North America
  • 7.6.1 North America Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.6.2 U.S.
    • 7.6.2.1 U.S. Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.6.3 Canada
    • 7.6.3.1 Canada Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
• 7.7 Europe
  • 7.7.1 Europe Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.7.2 U.K.
    • 7.7.2.1 U.K. Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.7.3 Germany
    • 7.7.3.1 Germany Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.7.4 France
    • 7.7.4.1 France Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.7.5 Italy
    • 7.7.5.1 Italy Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.7.6 Spain
    • 7.7.6.1 Spain Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
• 7.8 Asia Pacific
  • 7.8.1 Asia Pacific Transcutaneous Electrical Nerve StimulationMarket, 2017 - 2030 (USD Million)
  • 7.8.2 Japan
    • 7.8.2.1 Japan Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.8.3 China
    • 7.8.3.1 China (Mainland) Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.8.4 India
    • 7.8.4.1 India Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.8.5 South Korea
    • 7.8.5.1 South Korea Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.8.6 Australia
    • 7.8.6.1 Australia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
• 7.9 Latin America
  • 7.9.1 Latin America Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.9.2 Brazil
    • 7.9.2.1 Brazil Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.9.3 Mexico
    • 7.9.3.1 Mexico Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.9.4 Argentina
    • 7.9.4.1 Argentina Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.9.5 Colombia
    • 7.9.5.1 Colombia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
• 7.10 MEA
  • 7.10.1 MEA Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.10.2 South Africa
    • 7.10.2.1 South Africa Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.10.3 Saudi Arabia
    • 7.10.3.1 Saudi Arabia Transcutaneous Electrical Nerve Stimulation Market, 2017 - 2030 (USD Million)
  • 7.10.4 Saudi Arabia
    • 7.10.4.1 UAE Market, 2017 - 2030 (USD Million)

Chapter 8 Transcutaneous Electrical Nerve Stimulation (TENS) Market - Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, By Key Market Participants
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Company Profiles
  • 8.3.1 OMRON CORPORATION
    • 8.3.1.1 Company Overview
    • 8.3.1.2 Financial Performance
    • 8.3.1.3 Product Benchmarking
    • 8.3.1.4 Strategic Initiatives
  • 8.3.2 ZYNEX MEDICAL
    • 8.3.2.1 Company Overview
    • 8.3.2.2 Financial Performance
    • 8.3.2.3 Product Benchmarking
    • 8.3.2.4 Strategic Initiatives
  • 8.3.3 NEUROMETRIX, INC.
    • 8.3.3.1 Company Overview
    • 8.3.3.2 Financial Performance
    • 8.3.3.3 Product Benchmarking
    • 8.3.3.4 Strategic Initiatives
  • 8.3.4 EMS PHYSIO LTD.
    • 8.3.4.1 Company Overview
    • 8.3.4.2 Financial Performance
    • 8.3.4.3 Product Benchmarking
    • 8.3.4.4 Strategic Initiatives
  • 8.3.5 BIOMEDICAL LIFE SYSTEMS
    • 8.3.5.1 Company Overview
    • 8.3.5.2 Financial Performance
    • 8.3.5.3 Product Benchmarking
    • 8.3.5.4 Strategic Initiatives
  • 8.3.6 DJO GLOBAL, INC.
    • 8.3.6.1 Company Overview
    • 8.3.6.2 Financial Performance
    • 8.3.6.3 Product Benchmarking
    • 8.3.6.4 Strategic Initiatives
  • 8.3.7 GLOBUS
    • 8.3.7.1 Company Overview
    • 8.3.7.2 Financial Performance
    • 8.3.7.3 Product Benchmarking
    • 8.3.7.4 Strategic Initiatives